Bladder Cancer pp 161-187 | Cite as

The Treatment of Superficial Bladder Tumours

  • E. J. Zingg
  • D. M. A. Wallace
Part of the Clinical Practice in Urology book series (PRACTICE UROLOG)


Treating a patient with a superficial bladder tumour has responsibilities far beyond performing a good TUR of the tumour. Choosing the optimum treatment policy for the patient depends on the urologist having a wide understanding of the disease, a sound knowledge of bladder tumour pathology and a critical appraisal of all the therapeutic modalities available. Treatment is likely to be prolonged over many years, and the follow-up is an essential part of this treatment. The urologist must set out prepared to use all the available forms of treatment, including intravesical chemotherapy and total cystectomy. If he is not, the patient should be referred on at an early stage, rather than persist with ineffective treatment for this may deny the patient the opportunity of cure.


Bladder Cancer Bladder Tumour Transitional Cell Carcinoma Transurethral Resection Superficial Bladder Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abrams PH, Choa RG, Gaches CGC, Ashken MH, Green NA (1981) A controlled trial of single dose Adriamycin in superficial bladder tumours. Br J Urol 53: 585–587PubMedCrossRefGoogle Scholar
  2. Alfthan O, Tarkkanen J, Gröhn P, Heinonen E, Pyrhönen S, Säilä K (1983) Tigason (etretinate) in prevention of recurrence of superficial bladder tumours. A double-blind clinical trial. Eur Urol 9: 6–9PubMedGoogle Scholar
  3. Althausen AF, Prout GR, Daly JJ (1976) Non-invasive papillary carcinoma of bladder associated with carcinoma in situ. J Urol 116: 576–579Google Scholar
  4. Amar AD, Das S (1983) Vesicoureteric reflux in patients with bladder tumours. Br J Urol 55: 483–487PubMedCrossRefGoogle Scholar
  5. Anderström C, Johansson S, Nilsson S (1980) The significance of lamina propria invasion on the prognosis of patients with bladder tumours. J Urol 124: 23–26PubMedGoogle Scholar
  6. Augspurger RR, Donohue RE (1980) Prevention of obturator nerve stimulation during transurethral surgery. J Urol 123: 170–172PubMedGoogle Scholar
  7. Barnes R, Hadley H, Dick A, Johnston O, Dexter J (1977) Changes in grade and stage of recurrent bladder tumours. J Urol 118: 177–179PubMedGoogle Scholar
  8. Benson RC, Kinsey JH, Cortese DA, Farrow GM, Utz DC (1983) Treatment of transitional cell carcinoma of bladder with haematoporphyrin derivative phototherapy. J Urol 130: 1090–1095PubMedGoogle Scholar
  9. Booth CM, Kellett MJ (1981) Intravenous urography in the follow-up of carcinoma of the bladder. Br J Urol 53: 246–249PubMedCrossRefGoogle Scholar
  10. Boyd PJP, Burnand KG (1974) Site of bladder tumour recurrences. Lancet II: 1290–1292CrossRefGoogle Scholar
  11. Bracken B, McDonald MW, Johnson DE (1981) Cystectomy for superficial bladder cancer. Urology 18: 459–463PubMedCrossRefGoogle Scholar
  12. Burnand KG, Boyd PJR, Mayo ME, Shuttleworth KED, Lloyd-Davies RW (1976) Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma. Br J Urol 48: 55–59PubMedCrossRefGoogle Scholar
  13. Byar D, Blackard C (1977) Comparisons of placebo, pyridoxine and topical thiotepa in preventing recurrence of stage 1 bladder cancer. Urology 10 (6): 556–561PubMedCrossRefGoogle Scholar
  14. Catalona WJ (1981) Practical utility of specific red cell adherence test in bladder cancer. Urology 18: 113–117PubMedCrossRefGoogle Scholar
  15. Cifuentes Delatte L, Garcia de la Pena E, Vela Navarrette R (1982) Survival rates of patients with bladder tumours. An experience of 1744 cases (1950–1978). Br J Urol 54: 267–274PubMedCrossRefGoogle Scholar
  16. Cooper PH, Waisman J, Johnston WH, Skinner DG (1973) Severe atypia of transitional epithelium and carcinoma of the urinary bladder. Cancer 31: 1055–1060PubMedCrossRefGoogle Scholar
  17. Dalesio O, Schulman CC, Sylvester R, De Pauw M, Robinson M, Denis L, Smith P, Viggiano G (1983) Prognostic factors in superficial bladder tumours. A study of the European Organisation for Research on Treatment for Cancer: genitourinary tract cancer cooperative group. J Urol 129: 730–733PubMedGoogle Scholar
  18. Davis TRC (1983) The composition and origin of the gas produced during urological endoscopic resections. Br J Urol 55: 294–297PubMedCrossRefGoogle Scholar
  19. Dick A, Barnes R, Hadley H, Bergman RT, Ninan C (1980) Complications of transurethral resection of bladder tumours: prevention, recognition and treatment. J Urol 124: 810–811PubMedGoogle Scholar
  20. Eisenberg RB, Roth RB, Schweinsberg MH (1960) Bladder tumours and associated proliferative mucosal lesions. J Urol 84: 544–550PubMedGoogle Scholar
  21. England HR, Rigby C, Shepheard BGF, Tresidder GC, Blandy JP (1973) Evaluation of Helmstein’s distension method for carcinoma of the bladder. Br J Urol 45: 593–599PubMedCrossRefGoogle Scholar
  22. England HR, Paris AMI, Blandy JP (1981) The correlation of T1 bladder tumour history with prognosis and follow-up requirements. Br J Urol 53: 593–597PubMedCrossRefGoogle Scholar
  23. Esch W, Rummelhardt S (1973) Blasenteilresektion beim fortgeschrittenen Blasenkarzinom. Helv Chir Acta 40: 459–461PubMedGoogle Scholar
  24. Evard JP, Bollag W (1972) Konservative Behandlung der rezidivierenden Harnblasenpapillomatose mit Vitamin-A-Säure. Schweiz Med Wochenschr 102: 1880PubMedGoogle Scholar
  25. Falor WH, Ward RM (1977) Prognosis in well-differentiated noninvasive carcinoma of the bladder based on chromosomal analysis. Surg Gynecol Obstet 144: 515–518PubMedGoogle Scholar
  26. Fastenmeier K, Flackenecker G (1981) High frequency technology: applications and hazards. In: Mauermayer W (ed) Transurethral surgery. Springer, Berlin Heidelberg New York, pp 47–60Google Scholar
  27. Fitzpatrick JM, Khan O, Oliver RTD, Riddle PR (1979) Long term follow-up in patients with superficial bladder tumours treated with intravesical Epodyl. Br J Urol 51: 545–548PubMedCrossRefGoogle Scholar
  28. Gavrell GJ, Lewis RW, Meehan WL, Leblanc GA (1978) Intravesical thiotepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder. J Urol 120: 410–411PubMedGoogle Scholar
  29. Greene LF, Yalowitz PA (1972) The advisability of concomitant transurethral excision of vesical neoplasia and prostatic hyperplasia. J Urol 107: 445–447PubMedGoogle Scholar
  30. Gunter PA, de Abela-Borg J, Pugh RCB (1983) Urothelium and the specific red cell adherence test. Br J Urol 55: 10–16PubMedCrossRefGoogle Scholar
  31. Hall RR (1982) Report to the standing committee on urological instruments: Lasers in urology. Br J Urol 54: 421–426PubMedCrossRefGoogle Scholar
  32. Hall RR, Herring DW, Gibb I, Heath AB (1981) Prophylactic oral methotrexate therapy for multiple superficial bladder carcinoma. Br J Urol 53: 582–584PubMedCrossRefGoogle Scholar
  33. Hartung R, Hegemann M (1981) Implantationsmetastasen in den oberen Harnwegen durch resektionsbedingten vesikoureteralen Reflux. Aktuel Urol 12: 202–205CrossRefGoogle Scholar
  34. Helmstein K (1972) Treatment of bladder carcinoma by a hydrostatic technique. Report on 43 cases. Br J Urol 44; 434–450PubMedCrossRefGoogle Scholar
  35. Heney NM, Daly J, Prout GR, Nieh PT, Heaney JA, Trebeck NE (1978) Biopsy of apparently normal urothelium in patients with bladder carcinoma. J Urol 120: 559–560PubMedGoogle Scholar
  36. Heney NM, Nocks BN, Daly JJ, Prout GR, Newall JB, Griffin PB, Perrone TL, Szyfelbein WA (1982) Ta and T1 bladder cancer: Location recurrence and progression. Br J Urol 54: 152–157PubMedCrossRefGoogle Scholar
  37. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, Hawkins IR (1983) Superficial bladder cancer: progression and recurrence. J Urol 130: 1083–1086PubMedGoogle Scholar
  38. Hewitt CB, Babiszewski JF, Antunez AR (1981) Update on intracavitary radiation in the treatment of bladder tumours. J Urol 126: 323–325.PubMedGoogle Scholar
  39. Hinman F (1956) Recurrence of bladder tumors by surgical implantation. J Urol 75: 695–696PubMedGoogle Scholar
  40. Hisazumi H, Misaki T, Miyoshi N (1983) Photoradiation therapy of bladder tumours. J Urol 130: 685–687PubMedGoogle Scholar
  41. Hofstetter A, Schmiedt E, Staehler G (1982) Endovesikale Zerstoerung von Blasentumoren mit dem Neodym-YAG-Laser. Urologe [A] 21: 9–11Google Scholar
  42. Jewett HJ, Strong GH (1946) Infiltrating carcinoma of the bladder: relation of depth of penetration of the bladder wall to incidence of local extension and metastases. J Urol 55: 366–372PubMedGoogle Scholar
  43. Kelly JF, Snell ME, Berenbaum MC (1975) Photodynamic destruction of human bladder carcinoma. Br J Cancer 31: 237–244PubMedCrossRefPubMedCentralGoogle Scholar
  44. Kinsey JH, Cortese DA, Sanderson DR (1978) Detection of haematoporphyrin fluorescence during fibreoptic bronchoscopy to localise early bronchogenic carcinoma. Mayo Clin Proc 53: 594–600PubMedGoogle Scholar
  45. Laor E, Grabstald H, Whitmore WF (1981) The influence of simultaneous resection of bladder tumours and prostate on the occurrence of prostatic urethral tumours. J Urol 126: 171–172PubMedGoogle Scholar
  46. Lutzeyer W, Rubben H, Dahm H (1982) Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 127: 250–252PubMedGoogle Scholar
  47. Mackenzie N, Torti FM, Faysal M (1981) The natural history of superficial bladder tumours. Proc Am Assoc Cancer Res 22: 198Google Scholar
  48. Marberger H (1977) Die Transurethrale Resektion als Palliativbehandlung beim Blasenkarzinom. In: Verhandlungsbericht der Deutschen Gesellschaft für Urologie, vol 29. Springer, Berlin Heidelberg New York, p 19Google Scholar
  49. Marshall VF (1952) The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J Urol 68: 714–723PubMedGoogle Scholar
  50. Miller A, Mitchell JP, Brown NJ (1969) The British Bladder Tumour Registry. Br J Urol (Suppl), pp 1–64 (Chap 3 The natural history of bladder tumours, pp 17–25 )Google Scholar
  51. Narayana AS, Loening SA, Slymen DJ, Culp DA (1983) Bladder cancer: Factors affecting survival. J Urol 130: 56–60PubMedGoogle Scholar
  52. O’Flynn JD, Smith JM, Hanson JS (1975) Transurethral resection for the assessment and treatment of vesical neoplasms. Eur Urol 1: 38–40PubMedGoogle Scholar
  53. Page BH, Levison VB, Curwen MP (1978) The site recurrence of non-infiltrating bladder tumours. Br J Urol 50: 237–242PubMedCrossRefGoogle Scholar
  54. Page BH, Levison V, Curwen MP (1979) A trial of prophylactic radiotherapy for non-infiltrating bladder tumours. Br J Urol 51: 197–199PubMedCrossRefGoogle Scholar
  55. Pocock RD, Ponder BAJ, O’Sullivan JP, Ibrahim SK, Easton DF, Shearer RJ (1982) Prognostic factors in non-infiltrating carcinoma of the bladder: a preliminary report. Br J Urol 54: 711–715PubMedCrossRefGoogle Scholar
  56. Pryor JP (1973) Factors influencing the survival of patients with transitional cell tumours of the urinary bladder. Br J Urol 45: 586–592PubMedCrossRefGoogle Scholar
  57. Schade RO, Swinney J (1968) Precancerous changes in bladder epithelium. Lancet II: 943–946CrossRefGoogle Scholar
  58. Schade ROK, Swinney J (1983) The association of urothelial abnormalities with neoplasia: a 10-year follow-up. J Urol 129: 1125–1126PubMedGoogle Scholar
  59. Schellhammer PF, Whitmore WF (1976) Transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer. J Urol 115: 56–60PubMedGoogle Scholar
  60. Schulman CC, Robinson M, Denis L, Smith P, Viggiano G, de Pauw M, Dalesio O, Sylvester R (1982) Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: An EORTC randomised trial comparing thiotepa, an epipodophylotoxin (VM26) and TUR alone. Eur Urol 8: 207–212PubMedGoogle Scholar
  61. Smith G, Elton RA, Beynon LL, Newsam JE, Chisholm GD, Hargreave TB (1983) Prognostic significance of biopsy results of normal looking mucosa in cases of superficial bladder cancer. Br J Urol 55: 665–669PubMedCrossRefGoogle Scholar
  62. Soloway MS, Masters S (1980) Urothelial susceptibility to tumour cell implantation. Influence of cauterisation. Cancer 46: 1158–1163PubMedCrossRefGoogle Scholar
  63. Soloway MS, Murphy W, Rav MK, Cox C (1978) Serial multiple-site biopsies in patients with bladder cancer. J Urol 120: 57–59PubMedGoogle Scholar
  64. Soto EA, Friedell GH, Tiltman AJ (1977) Bladder cancer as seen in giant histologic sections. Cancer 39: 447–455PubMedCrossRefGoogle Scholar
  65. Studer UE, Biedermann C, Chollet D, Karrer P, Kraft R, Toggenburg H, Vonbank F (1984) Prevention of recurrent superficial bladder tumours by oral etretinate: preliminary results of a randomised, double blind multicenter trial in Switzerland. J Urol 131: 47–49PubMedGoogle Scholar
  66. Toggenburg H, Brand H (1979) Die klinische Bedeutung der Vesikorenalen Reflux nach Elektroresektion von Blasentumoren. Helv Chir Acta 46: 405–408PubMedGoogle Scholar
  67. Tsuchiya A, Obara N, Miwa M, Ohi T, Kato H, Hayata Y (1983) Haematoporphyrin derivative and laser photoradiation in the diagnosis and treatment of bladder cancer. J Urol 130: 79–82PubMedGoogle Scholar
  68. van der Werf-Messing BHP (1978) Cancer of the urinary bladder treated by interstitial radium implant. Int J Radiat Oncol Biol Phys 4: 373–378PubMedCrossRefGoogle Scholar
  69. van der Werf-Messing BHP, Hop WCJ (1981) Carcinoma of the urinary bladder (category T1NXM0) treated either by radium implant or by transurethral resection only. Int J Radiat Oncol Biol Phys 7: 299–303PubMedCrossRefGoogle Scholar
  70. Varkarakis MJ, Gaeta J, Moore RH, Murphy GP (1974) Superficial bladder tumour. Aspects of clinical progression. Urology 4: 414–420PubMedCrossRefGoogle Scholar
  71. Wallace DMA, Hindmarsh JR, Webb JN, Busuttil A, Hargreave TB, Newsam JE, Chisholm GD (1979) The role of multiple mucosal biopsies in the management of patients with bladder cancer. Br J Urol 51: 535–540PubMedCrossRefGoogle Scholar
  72. Walzer Y, Soloway MS (1983) Should the follow-up of patients with bladder cancer include routine excretory urography? J Urol 130: 672–673PubMedGoogle Scholar
  73. Weldon TE, Soloway MS (1975) Susceptibility of urothelium to neoplastic cellular implantation. Urology 5: 824–827PubMedCrossRefGoogle Scholar
  74. Whitmore WF, Prout GR (1982) Discouraging results for high dose external beam radiation therapy in low stage (O and A) bladder cancer. J Urol 127: 902–905PubMedGoogle Scholar
  75. Williams GB, Trott PA, Bloom HJG (1981) Carcinoma of the bladder treated by interstitial irradiation. Br J Urol 53: 221–224PubMedCrossRefGoogle Scholar
  76. Williams JL, Hammonds JC, Saunders N (1977) T1 bladder tumours. Br J Urol 49: 663–668PubMedCrossRefGoogle Scholar
  77. Wolf H, Hojgaard K (1983) Prognostic factors in local surgical treatment of invasive bladder cancer, with special reference to the presence of urothelial dysplasia. Cancer 51: 1710–1715PubMedCrossRefGoogle Scholar
  78. Zincke H, Garbeff PJ, Beahrs JR (1984) Upper tract transitional cell cancer after radical cystectomy for bladder cancer. J Urol 131: 50–52PubMedGoogle Scholar
  79. Zingg EJ, Zeltner T (1980) Partial cystectomy. In: Pavone-Macaluso M, Smith PH, Edsmyr F (eds) Bladder tumours and other topics in urological oncology. Plenum, New York, pp 201–205CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • E. J. Zingg
  • D. M. A. Wallace

There are no affiliations available

Personalised recommendations